Enregistrement - Lobbyistes salariés d'entreprises

Objets

• Commerce international
• Industrie
• Propriété intellectuelle
• Santé
• Sciences et technologies

Détails sur l'objet

Politique ou Programme

• Canada's orphan drug framework as it relates to reimubursement recommendations in Canada, and also in regards to the alingment of the framework with processess that are already implemented in the US and EU.
• Canadian Agency for Drugs and Technologies in Health (CADTH), including Therapeutic Reviews and the Common Drug Review as it relates to reimbursement recommendations for decision-making process and framework.
• Federal Public Drug Plans, with respect to the reimbursement of drug products for the Federal plan beneficiaries
• Science and Technology Strategy, advocating for the development of a Biopharma sector in support of more research & development in Canada.

Politique ou Programme, Règlement

• Subsequent Entry Biologics (SEBs): information regarding approval framework supported and protected by Regulations in harmonization with approaches taken by the European Union or the U.S. for instance.

Proposition législative, Projet de loi ou résolution

• Food and Drugs Act & Regulations as it relates to Drug Export restriction and cross border trade.
• The bill, formerly known as Bill C-6, Canada Consumer Product Safety Act with respect to creating a new system to regulate consumer products that pose, or might reasonably be expected to pose, a danger to human health and safety.
• Trans Pacific Partnership - Novartis is working through our Industry Association Rx&D on the monitoring of this potential trade agreement and the impact to Intellecutal Property (IP) in Canada

Proposition législative, Projet de loi ou résolution, Règlement

• Bill C-17 - monitoring the implementation of the revised Food and Drugs Act Vanessa's Law (and Regulations)
• CETA implementation - Novartis is working through our Industry association, Rx&D on the implementation of this trade agreement

Règlement

• Patented Medicine Prices Review Board (PMPRB) Regulations as related to reporting requirements and pricing guidelines.
• Patented Medicines (Notice of Compliance) Regulations as it relates to regulation of intellectual property for therapeutic products.

Techniques de communication

• Communication écrite
• Communication orale

Institutions gouvernementales

• Affaires étrangères, Commerce international et Développement
• Agence de promotion économique du Canada atlantique (APECA)
• Anciens Combattants Canada (ACC)
• Conseil d'examen du prix des médicaments brevetés (CEPMB)
• Défense nationale (MDN)
• Industrie Canada
• Santé Canada (SC)

Adresse :
385 Bouchard Blvd.
Dorval, QC  H9S 1A9
Canada

Numéro de téléphone : 514-631-9219
Numéro de fax : 514-717-9219  

Renseignements sur la société mère